通过Mgat5的N-糖化对免疫媒介瘤清除施加了可向的约束
Erin E Hollander1,2, Rosemary E Flock3, Jayne C McDevitt1,2
1Department of Medicine and.
JCI insight
|June 24, 2024
概括
N-乙葡萄糖胺基转移酶V (Mgat5) 对胰腺癌的生长和转移至关重要. 失去Mgat5增强了抗瘤免疫力和对T细胞中介死亡的敏感性,改善了免疫治疗的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 异常的蛋白质糖化是癌症的标志,影响瘤的进展和免疫规避.
- N-乙葡萄糖胺基转移酶V (Mgat5) 促进复杂的N-甘氨酸的形成,与瘤生长和转移有关.
- 胰腺管腺癌 (PDAC) 呈现出显著的免疫异质性,影响治疗反应.
研究的目的:
- 调查Mgat5在PDAC瘤生长和免疫监测中的作用.
- 确定Mgat5缺乏对抗瘤免疫反应和对T细胞介导细胞死亡的敏感性的影响.
- 评估针对免疫治疗耐药PDAC中的Mgat5的治疗潜力.
主要方法:
- 使用了一组小鼠PDAC克隆细胞系的面板,具有不同的免疫特征.
- 在Mgat5淘汰赛后评估体内和体外瘤生长.
- 分析了免疫细胞透 (T细胞,树突细胞,NK细胞) 和外部细胞死亡途径.
- 在Mgat5缺乏的PDAC模型中评估瘤对免疫检查点阻塞的反应.
主要成果:
- 在体内,Mgat5缺乏会影响PDAC瘤的生长,但在体内并非如此.
- 失去Mgat5导致T细胞和树突细胞依赖瘤清除,早期NK细胞参与.
- 缺乏Mgat5的细胞对TNF超级家族介导的细胞死亡敏感度增加.
- 免疫治疗耐药PDAC线的Mgat5淘汰减少了瘤生长,并在免疫检查点封锁时改善了存活率.
结论:
- Mgat5在PDAC瘤生长和免疫逃避中发挥着关键作用.
- 向Mgat5可以增强抗瘤免疫力,并通过T细胞媒介杀死癌细胞.
- 抑制Mgat5是一种潜在的治疗策略,可以克服PDAC中的免疫疗法耐药性.
相关概念视频
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511


